The Psychology of Impact in Pharma
Here, we explore the application of the SCARF (status, certainty, autonomy, relatedness, and fairness) model, learned helplessness, and locus of control to the assessment of impact in the pharmaceutical industry and describe approaches by which hesitancy can be overcome.
Are we truly measuring what matters in Medical Affairs?
This article summarizes an engaging Roundtable discussion, emphasizing the transformative influence of metrics, data, and technology, particularly Artificial Intelligence (AI), on the strategic role of Medical Affairs.
The Future is Agentic: Unlocking AI’s Potential for Medical Insights
Discover how Agnetic is harnessing AI to revolutionize healthcare, unlocking powerful medical insights for better, faster, and more personalized care.
Operationalizing Medical Strategy: A Success Story in Demonstrating Value and Impact
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
A Rapidly Changing Regulatory Landscape: What Medical Affairs Leaders Should Know
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
Piloting GenAI in Medical Information: Lessons from the Front Lines
In today’s “Elevate” episode, our speaker panel, lead by Jennifer Riggins and Steve Casey of the MAPS Digital Strategy FAWG, dives into a topic at the cutting edge of medical information: the use of Generative AI for content creation.
Work Smarter, Publish Stronger: Data-Driven Targeting
This episode defines crisis management as a structured, cyclical process: preparedness, response, recovery, and reflection. We discuss how Medical Affairs plays a unique role in translating uncertainty into strategy, maintaining scientific clarity, and protecting external trust through transparent communication.